Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study

Genital warts (GWs) are common, with about 5% to 10% of people having at least one episode in their lifetime. They develop about 2–3 months after infection with human papillomavirus (HPV) genotypes 6 and 11. The prophylactic quadrivalent HPV vaccine (qHPV), protects against HPV6/11 infections and di...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominiak-Felden, Geraldine, Gobbo, Corrado, Simondon, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492693/
https://www.ncbi.nlm.nih.gov/pubmed/26147096
http://dx.doi.org/10.1371/journal.pone.0132404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492693/
https://www.ncbi.nlm.nih.gov/pubmed/26147096
http://dx.doi.org/10.1371/journal.pone.0132404

Ejemplares similares